A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors

Summary

The purpose of this study is to determine the Maximum Tolerated Dose and the Dose-Limiting Toxicity of the drug to further evaluate safety and antitumor activity.

Timeline

Start

2012-08

Primary completion

2015-03

Completion

2015-08

Outcome

Outcome not reported

Stopped: “Study was prematurely discontinued due to unacceptable toxicity.”

Drugs

Indications